Altimmune (ALT) Depreciation & Amortization - Total: 2012-2017

Historic Depreciation & Amortization - Total for Altimmune (ALT) over the last 4 years, with Mar 2017 value amounting to $33,007.

  • Altimmune's Depreciation & Amortization - Total fell 12.45% to $33,007 in Q1 2017 from the same period last year, while for Mar 2017 it was $138,743, marking a year-over-year decrease of 2.43%. This contributed to the annual value of $143,437 for FY2016, which is 1.29% up from last year.
  • Altimmune's Depreciation & Amortization - Total amounted to $33,007 in Q1 2017, which was down 0.18% from $33,066 recorded in Q4 2016.
  • Over the past 5 years, Altimmune's Depreciation & Amortization - Total peaked at $52,602 during Q1 2013, and registered a low of $32,235 during Q3 2016.
  • Over the past 3 years, Altimmune's median Depreciation & Amortization - Total value was $35,005 (recorded in 2015), while the average stood at $35,339.
  • Per our database at Business Quant, Altimmune's Depreciation & Amortization - Total slumped by 38.45% in 2013 and then increased by 10.22% in 2016.
  • Quarterly analysis of 5 years shows Altimmune's Depreciation & Amortization - Total stood at $43,438 in 2013, then fell by 15.54% to $36,686 in 2014, then decreased by 10.58% to $32,806 in 2015, then grew by 0.79% to $33,066 in 2016, then dropped by 12.45% to $33,007 in 2017.
  • Its Depreciation & Amortization - Total stands at $33,007 for Q1 2017, versus $33,066 for Q4 2016 and $32,235 for Q3 2016.